Clinical Trial Update: Study of Tadalafil Once-a-Day for 12 Weeks in Japanese Men With Benign Prostatic Hyperplasia Followed by an Open-Label Extension [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating once-daily tadalafil for 12 weeks in Japanese men with benign prostatic hyperplasia, followed by an open-label extension, has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Cialis (tadalafil)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Benign Prostatic Hyperplasia | Phase 2 | Status: COMPLETED | Results posted: 2010-07-28